PECULATION THAT a single common progenitor cell could give rise to both the supportive and structural elements of the bone as well as the hematopoietic marrow cells has been made since early this century.',' Although hematopoietic cell differentiation in bone marrow (BM) has been extensively described, the ontogeny of the stromal compartment of BM has only recently been e~p l o r e d .~.~ Heterogeneity within the stromal cell pool is apparent by the large variety of cellular morphologies and by the differing capacities of various stromal cell lines to support hematopoie s i~.~-~ Understanding the ontogeny of the stromal cells in the BM would help elucidate the different pathways of stromal cell differentiation and the different functional properties of these cells.
There have been a number of studies that support, to a limited degree, the "common stem cell" hypothesis. Based on an analysis of the proximity of hematopoietic and stromal cells in the periosteum of human fetal BM, Islam'" hypothesized that a single cell can differentiate along both a hematopoietic and a stromal lineage. Analysis of clonal glucose-6-phosphate dehydrogenase (GAPDH) expression in hematopoietic and stromal cells in long-term BM cultures characteristics and growth properties of hematopoietic progenitor cells. In contrast, the CD50-fraction lacked hematopoietic progenitor activity but contained clonogenic stromal progenitors at a mean frequency of 5%. We tested the hypothesis that cultures derived from single cells with the CD34+, CD38-, HLA-DR-phenotype could differentiate along both a hematopoietic and stromal lineage. The cultures contained a variety of mesenchymal cell types and mononuclear cells that had the morphologic appearance of histiocytes.
lmmunophenotyping of cells from these cultures indicated a stromal rather than a hematopoietic origin. In addition, the growth of the histiocytic cells was independent of the presence or the absence of hematopoietic growth factors. Based on sorting more than 30,000 single cells with the CD34'. CD38-, HLA-DRphenotype into individual culture wells, and an analysis of 864 stromal cultures initiated by single CD34+ BM cells, this study does not support the hypothesis of a single common progenitor for both hematopoietic and stromal lineages within human fetal BM. established from patients with chronic myelogenous leukemia (CML) and acute nonlymphocytic leukemia (ANLL) indicated the existence of a stem cell that is common to both the hematopoietic and stromal lineages in these patients."
The generation of clusters of round cells that appeared to be hematopoietic in origin has been reported in SV40-transformed human BM stromal cell lines and in long-term cultures of mouse and rat BM.I2-I4 The expression of the CD34 antigen on both hematopoietic stem c e l l~'~~~' ' and stromal progenitors4'*' isolated from the BM suggests the idea of a common stem cell for both lineages." Studies using fluorescence-activated cell sorting (FACS) and in vitro culture have established that the CD34+, CD38-fraction of BM contains most of the early hematopoietic and the CD34+, Stro-l+ fraction contains most of the stromal prog e n i t o r~. *~~~~ However attractive the hypothesis of the common stem cell, solid evidence for the existence of such a cell in normal BM has not been found. Indeed, in a previously published report,22 two investigators of the present study (S.H. and L.T.) claimed that a single, common BM stem cell can differentiate along both hematopoietic and stromal lineages, based primarily on morphologic analyses of the clusters of round cells that developed from stromal cell cultures initiated by single, FACS-sorted CD34+, CD38-, HLA-DR-cells. However, these investigators subsequently retracted the conclusions of their report, leaving open the question of whether such a common stem cell exists.2h We have subsequently undertook further, more extensive studies to clarify the nature of the cell types that can be generated from such fetal BM-derived CD34+, CD38-components. We wished to determine whether an experimental approach based on isolating individual BM stromal progenitor cells by FACS and culturing them in a variety of different media could elucidate their For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From growth properties in vitro and their ontologic relationship to cells of the hematopoietic lineages. Our objective was to test the hypothesis that a single BM cell could initiate a culture that contained both hematopoietic and stromal progeny.
MATERIALS AND METHODS

FACS.
Human fetal BM from 14-to 24-week gestation fetuses was obtained from Advanced Bioscience Resources, Inc (Alameda, CA). Single-cell suspensions of fetal BM were prepared by flushing the BM cells out of the humeri and femurs using a syringe and a 22-gauge needle into phosphate-buffered saline (PBS) containing 1% wt/vol bovine serum albumin (BSA). The low-density mononuclear cell fraction of BM was obtained by centrifuging the cell suspension over a Ficoll step gradient (density, 1.077 g/mL) and collecting the buoyant cell fraction. The yield of mononuclear cells from each fetal sample ranged from 1 X lo6 to 100 X IO6 cells from two femurs. For cell sorting, cell suspensions were stained with saturating concentrations of the following monoclonal antibodies (MoAbs): (l) CD34-allophycocyanine (APC), CD38-phycoerythrin (PE), and HLA-DR-fluorescein isothiocyanate (FITC); (2) CD34-APC, CD38-PE plus HLA-DR-PE, and CD5O-FITC, or (3) CD34-APC, CD38-PE. and HLA-DR-FITC plus CD5O-FITC. Single cells were sorted into the individual wells of a 96-well tissue culture plate containing cell culture media using a FACS Vantage cell sorter (Becton Dickinson Immunocytometry Systems [BDIS], San Jose, CA) equipped with an automatic cell deposition unit (ACDU), a Coherent Enterprise laser tuned at 488 nm (100 mW), and a Coherent Spectrum laser tuned at 647 nm (100 mW). For cell analysis, 1 X lo6 cells were stained first with CD3, CDlO, CD19, CD13, CD14, CD15, CD36 (GPIIIb), CD43, CD49b, CD49d, CD49e, CD50 (intercellular adhesion molecule-3 [ICAM-3]), CD54 (ICAM-l), CD62E (E-Selectin), CD90w (Thy-l), CD105 (Endoglin), or CD106 [vascular cell adhesion molecule-l (VCAM-l)], followed by a washing step and staining with PE-conjugated goat-antimouse Ig antisera (Jackson Research Laboratories, West Grove, PA). After a wash step, normal mouse serum was added for 10 minutes, followed by staining with CD34 perdinin chlorophyll protein, CD38-APC, and HLA-DR-FlTC. The APC and PerCP conjugates were provided by Barny Abrams and Quadrat Nasarati in the Research Department of BDIS. CD50 was provided by Ramon Vilella (Servei D-Immunologia Hospital Clinic, Barcelona, Spain). CD105 and CD90w were obtained from the Fifth International Workshop, and all other antibodies were from BDIS or Becton Dickinson Cellular Imaging Systems (BDCIS). Cell analysis was performed on a modified FACScan configured by Bob Hofman in the Research Department of BDIS. The flow cytometer was equipped with a 12-mW Argon ion laser (488 nm), a 30-mW YAG laser (532 nm), and a IO-mW HeNe laser (633 nm). PE was excited with the YAG laser, which results in a sixfold increase in sensitivity as compared with excitation at 488 nm. Data analysis was performed with the Paint-A-GatePLUS software program (BDIS).
Tissue culture. Tissue culture media consisted of the Terry Fox long-term myeloid media (TF) supplemented with one of three combinations of growth factors: medium 1: 10 ng/mL insulin growth factor-l (IGF-l) and 2.5 ng/mL basic fibroblast growth factor (bFGF); medium 2: a mixture of hematopoietic growth factors consisting of 10 ng/mL interleukin (IL)-3, 500 U/mL IL-6, 10 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF), 2.5 U/mL erythropoietin (EPO; AMGEN, Thousand Oaks, CA), 50 ng/ mL stem cell factor (SCF; Genzyme, Cambridge, MA), plus 10 ng/ mL IGF-l and 2.5 ng/mL bFGF; or medium 3: TF supplemented with different combinations of IGF-1, bFGF, 10 ng/mL plateletderived growth factor (PDGF), and 10 ng/mL epidermal growth factor (EGF). Unless otherwise specified, growth factors were obtained from Collaborative Research (Bedford, MA). In unfractionated BM, stromal cell growth was determined in serum-free medium supplemented with IGF-l or bFGF (GIBCO 15A and GIBCO 16A; provided by GIBCO). Tissue culture plates were kept at 37°C in a 5% voUvol CO, humidified atmosphere. Single cells with CD34+, CD38-, CD50-, HLA-DR-phenotypes were deposited into individual wells of a 96-well tissue culture plate. Each well contained either 200 pL of cell culture media containing TF + bFGF + IGF-1 (medium l), or the same media supplemented with the mixture of hematopoietic growth factors described above (IL-3, L-6, EPO, GM-CSF, and SF; medium 2). The growth of the sorted cell in each well was determined by visual inspection after 3,7, 14, and 21 days of culture. Wells were scored as positive when they contained more than 50 cells after 14 to 21 days of culture. The culture media of established cultures of hematopoietic and stromal cells were refreshed every 2 weeks by removing half of the culture media and replacing it with fresh media. Stromal cell cultures were replated by mechanically disaggregating the adherent cell monolayer on the more complex structures and replating the dispersed cells into new tissue culture wells containing fresh media every 2 to 3 weeks. Nonadherent cells were removed from the stromal cell layers or stromal cell structures using a micropipette and an inverted microscope.
Immunophenotyping of cultured cells. Cytospins were prepared from the nonadherent cell populations derived from cultured single cells. Single-cell suspensions obtained from the cultured cells were centrifuged at 1 ,000 rpm for 5 minutes and then resuspended in PBS plus BSA at a concentration of 2 X lo4 cells per milliter, and 5 X l@ cells were deposited onto a glass slide by centrifugation in a Shannon I1 Cytocentrifuge (Shannon Inc, Pittsburgh, PA). The cells were allowed to dry in air and then stained with Wright-Giemsa or fixed by a brief immersion in acetone. Fixed slides were then immunophenotyped by Dr Onsi W. Kame1 (Department of Pathology, Stanford University Medical School, Stanford, CA) using a biotin-streptavidin technique that we have previously described." In brief, slides were sequentially incubated with 3% voVvol Hz02 in PBS, incubated with an unlabeled mouse primary antibody, incubated with a diluted biotin-goat antimouse sera, incubated with the appropriate dilution of streptavidin-conjugated horseradish peroxidase (Jackson Research Laboratories). Each incubation was followed by washing the slides in PBS. The presence of bound primary antibody was shown by developing the peroxidase reaction with 3% diaminobenzidine, and then the slides were lightly counterstained with methylene blue. The primary antibodies used for this study were CD45RB, CD49b, CDlO, CD13, CD3, CD43, and CD50.
FACS analysis of cultured cells. Nonadherent round cells that developed from cultured stromal cells were analyzed on the experimental flow cytometer described above. Cell suspensions containing 0.5 X lo6 to 1 X lo6 cells in 100 pL PBS plus BSA were incubated with 20 pL of each diluted MoAb that had been directly conjugated to a fluorochrome. The following antibodies were used: CDllc-CD45-FITC, CD49b-APC. HLA-DR-PerCP, CD5O-FITC, and CD68-APC. Scatter gates were set to exclude debris with very low forward scatter or very high side scatter, and 30,000 gated events were collected for each sample.
CD38-, HLA-DR-, CD34+, CD38-, HLA-DR+, and CD34+, APC, CD13-PE, CDICFITC, CD19-PE, CD34-APC, CD43-PE, The expression of HLA-DR is correlated with reactivity to an isotype control antibody and antibodies to CD3, CD50, CD49d, CD49e, and CD49b. The HLA-DR+ cells stained as a homogeneous population for all the MoAbs shown. The CD34+, CD38-, HLA-DR+ cells were uniformly positive for CD50, CD49d, and CD49e and showed no specific staining with the isotype control antibody and antibody to CD3. The CD34+, CD38-, HLA-DR+ cells were mainly contained within a specific light scatter location, slightly larger than that of B lymphocytes, as indicated by the arrow in the top row, left panel.
RESULTS
Phenoopic characterization
In contrast, the HLA-DR-fraction of CD34+, CD38-cells had more heterogeneous light scatter properties and staining patterns with a variety of other MoAbs compared with the HLA-DR+ fraction. The HLA-DR-cells had a higher autofluorescence and showed absence of specific staining with the isotype control antibody and with the antibody to CD3. The HLA-DR-cells could be subdivided into two populations that were either positive or negative for the expression of CD49b, CD49d, and CD50; and divided into three populatiowthat were either negative, dim, or positive for the expresion of CD49e. Additional phenotypic analysis showed no significant expression for the CD14, CD15, and CD19 antigens on either the HLA-DR+ or the HLA-DR-populations of CD34+, CD38-cells. The majority of cells in both the HLA-DR-and HLA-DR+ fractions expressed the CD13, CD49e, CD54, CD90w, and CDlOS/endoglin antigens. The expression of the CD10, CD36, CD49b, CD62E, and CD106/ VCAM antigens were lacking in the HLA-DR+ cells and variable in the HLA-DR-cells. Comparing the light scatter profiles and the relative frequencies of the different subpopulations within the CD34', CD38-, HLA-DR-cells suggested that those that expressed CD49b also lacked expression of CD49d and CD50.
These results indicate that the CD34+, CD38-, HLA-DR+ cells are a relatively homogenous population with an antigenic profile consistent with that of a hematopoietic progenitor cell. In contrast, the CD34+, CD38-, HLA-DR-cells were more heterogeneous: a smaller subset (10% to 40%) showed staining identical to the HLA-DR+ population, whereas the larger fraction showed antigenic features consistent with a stromal origin. As CD50 expression has been reported to be restricted to hematopoietic cells" and this marker split the HLA-DR-cells into two well-defined populations, it was used in the further characterization of the CD34+, CD38-, HLA-DR-subsets.
FACS analysis of single sorted CD34+, CD38-cells. The phenotypic analysis suggested that there were subpopulations of CD34+, CD38-, HLA-DR-cells that expressed different combinations of hematopoietic-and stromal-associated cell markers. If a common stem cell exists, it would likely be found among cells with the CD34+, CD38-, HLA-DR-phenotype. We hypothesized that a growth medium containing serum, bFGF, and IGF-1 (medium 1) would support stromal (and not hematopoietic) differentiation of the putative common stem cell, whereas a medium containing serum, bFGF, IGF-1, and a mixture of hematopoietic growth factors (medium 2) would permit the differentiation of a single common stem cell along either a hematopoietic a n d or a stromal lineage. By analogy to the fluctuation assay, if 5% of the sorted cells were clonogenic common stem cells and formed stromal colonies (but no hematopoietic colonies) in medium 1, sorting the same number of bipotential clonogenic cells into medium 2 might result in 5% hematopoietic colonies and no stromal colonies, indicating the preferential differentiation of a common stem cell along a hematopoietic lineage in medium 2.29 Based on the phenotypic analysis by FACS shown in Fig 1, we divided CD34+, CD38-cells into four subpopulations HLA-DR-, HLA-DR-KDSO-, HLA-DR-/CDSO+, and HLA-DR+ and analyzed the growth potential of single cells cultured in either medium 1 or 2.
The gates used for cell sorting are shown in Fig 2. Panel A shows the light scatter characteristics of fetal BM cells and the light scatter gate used. Cells with a very low forward light scatter were excluded, because this population had a lower frequency of clonogenic stromal cells compared with cells with the same surface phenotype with a higher forward light scatter. Panel B shows the correlation of CD34-APC and CD38-PE and the fluorescence gate used for sorting. Panel C shows the expression of HLA-DR on the cells gated on light scatter, CD34, and CD38. Gate 1 represents the sorted CD34+, CD38-, HLA-DR-cells, and gate 2 was used to sort the CD34+, CD38-, HLA-DR+ cells. In separate experiments in which the cells were stained with CD34-APC, CD5O-FITC, and a combination of HLA-DR-PE and CD38-PE MoAbs. Panel D shows the expression of CD38 HLA-DR and CD50 on the cells gated on light scatter and CD34. Gate 3 was used to sort CD34+, CD38-, HLA-DR-, CD50-cells. In a separate set of experiments, the CD34+, CD38-, HLA-DR-, CD50+ cells shown to the right of gate 3 in panel D were sorted into medium 1 and medium 2. In each of the experiments, the pulse width of the forward light scatter signal was measured, and cells with a large signal were excluded from the sorts to eliminate cell doublets. A total of 31 different experiments involving single cell sorting of over 30,000 CD34+, CD38-cells were performed. In 12 experiments CD34+, CD38-, HLA-DR-cells were sorted into media 1 using various scatter gates to optimize the recovery of stromal progenitors. In these experiments, the mean frequency of clonogenic cells in the total population of CD34+, CD38-, HLA-DR-cells (using scatter gates that included small as well as large cells) was 1.6% (?SD, 1.9%; n = 3). The frequency of clonogenic cells in the large population of CD34+, CD38-, HLA-DR-cells (using scatter gates that included only cells larger than the 60th percentile in forward scatter) was 3% (+SD, 4%; n = 6). In contrast, the mean frequency of CD34+, CD38-, HLA-DR-cells in the small population (less than the 60th percentile in forward scatter) was 0.7% (?SD, 0.4%; n = 5). Based on these data, only the large CD34+, CD38-, HLA-DR-cells were sorted in subsequent experiments. In 15 experiments, CD34+, CD38-cells with each of three phenotypes (HLA-DR-, I B.
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HLA-DR-ICDSO-, and HLA-DR") were sorted into both media 1 and 2. In the remaining four experiments, CD34+, CD38-, HLA-DR-, CD50+ cells were sorted into medium 1 andor 2.
Growth properties of single sorted CD34+, CD38-cells.
Serial observations of each culture well that received a singly sorted cell were performed after 3, 7, 14, and 21 days. The earliest point at which the growth of a singly sorted cell could be detected was after 3 days of culture. Usually, three to eight cells were observed that were either adherent and fibroblastic in appearance or round and nonadherent. After 7 days of culture, some additional wells, initially scored as negative at 3 days, now demonstrated the growth of either round or adherent cells. Between 7 and 14 days culture, the types of cells growing in each positive well were classified based on their morphology by light microscopy. The wells were scored for four different initial growth patterns shown in Fig 3: pattern 1: the appearance of adherent, fibroblastlike cells scattered in a random pattern across the surface of the culture well ( Fig 3A) ; pattern 2: the appearance of dispersed, round large cells ( Fig 3B) ; pattern 3: the appearance of a mixture of nonadherent blast cells and clusters of round cells ( Fig 3C) ; and pattern 4: the appearance of slightly adherent trapezoidal cells that also formed clusters of cells (Fig 3D) . Morphologic and immunohistologic analyses of Observations at 14 and 21 days of culture showed continued growth of the adherent, fibroblastic cells (growth pattern l ) into colonies of IO2 to Io" cells, and their orientation into swirls of cells growing in parallel across the surface of culture plate in both medium l and medium 2. The round, nonadherent cells that were initially dispersed (growth pattern 2) or clumped (growth patterns 3 and 4) multiplied to a much greater extent in the presence of hematopoietic growth factors (greater than IO4 cells in medium 2) than in their absence (less than 10' cells in medium l). Based on these data, singly sorted cells whose initial growth pattern at 14 to 21 days was that of pattern 2, 3, or 4 were considered to be hematopoietic in origin, while cells that yielded cultures whose initial growth pattern was that of pattern I were considered to be stromal in origin. In no case in which single CD34+, CD38-, HLA-DR-cells were sorted did we observe a mixed colony that contained both adherent, fibroblastic cells and nonadherent round or trapezoidal cells after 3 weeks of initial culture. After 21 days of culture, the adherent, fibroblastic cells began to organize into long strands of fibrous matrix and cells that were suspended above the surface of the culture well. In the absence of additional fresh
, the cultures of round, nonadherent cells in medium 2 showed evidence of cell death after more than 21 days of culture. Cultures of round, nonadherent cells were harvested for morphology and immunophenotyping or replated between IO and 21 days of culture. Fibroblastic cell cultures were harvested after 21 to 28 days of culture.
The frequency of stromal progenitors in the CD34', CD38-populdon did not differ between medium I and medium 2. Over 18,000 single fetal BM cells were sorted from 15 separate fetal BM samples into either medium 1 or medium 2. The frequencies at which individual CD34+, CD38-cells with the HLA-DR-, HLA-DR-/CD50-, or the HLA-DR' phenotypes formed stromal (growth pattern 1) or hematopoietic colonies (patterns 2, 3, and 4) are shown graphically in Fig 4. There were no significant differences in the relative frequencies of stromal progenitors between the CD34', CD38-, HLA-DR-and the CD34', CD38-, CD50-, HLA-DR-populations in either media, thus refuting the hypothesis that a subpopulation of bipotential cells might preferentially differentiate along a hematopoietic lineage in the presence of hematopoietic growth factors. There was considerable variation in the relative frequencies of clonogenic cells from experiment to experiment. We noted that the total frequency of stromal cell growth was slightly higher from singly sorted cells sorted with the CD34+, CD38-, HLA-DR-phenotype than with cells sorted with the CD34+, CD38-, HLA-DR-, CD50-phenotype (4.7% of sorted HLA-DR-cells. n = 15, v 3.3% of sorted HLA-DR-KDSO-cells, n = 1 l ) . This difference was due to four experiments in which only the HLA-DR-sort was performed on young fetal samples, in which there was a higher stromal cell cloning 2427 efficiency (1.2%, 16.5%, 10.4%, and 24%) than in the average experiment. Comparing the mean frequencies of stromal cell growth in single cells that showed either stromal or hematopoietic growth in the I 1 experiments in which both the CD34", CD38-, HLA-DR-and the HLA-DR-/CDSOsorts were performed showed that the frequency of stromal cell progenitors was equal in the HLA-DR. and HLA-DR-/ CD50-fractions of CD34'. CD38-cells (Table l) . Both the HLA-DR-and HLA-DR-/CDSO-fractions had significantly higher numbers of stromal progenitors than the HLA-DR" population, with P values of less than .02. These data demonstrate that isolating stromal cell populations with similar phenotypes using two different combinations of fluorochrome-conjugated MoAbs (CD34-APC, CD38-PE, HLA-FITC) gave essentially identical results.
Hematopoietic progenitors were present both in the HLA-DR-and HLA-DR' fractions of CD34', CD38-cells and were lacking in the HLA-DR-/CDSO-population. There were more than IO times more hematopoietic progenitors in the HLA-DR' fraction of CD34", CD38-cells compared with the HLA-DR-population in media 2 ( P < .0o01; Table   l ). Within the HLA-DR' and HLA-DR-fractions, the growth and proliferation of hematopoietic cells was dependent on the presence of hematopoietic growth factors ( P < .01 and P < .0o01, respectively). The frequency of hemato- Initial growth patterns of single CD34' . CD38-, HLA-DR-cells sorted into TF long-term myeloid media containing a mixture of hematopoietic growth factors consisting of 10 ng/mL IL-3, 500 U/ mL IL-6, 10 ng/mL GM-CSF, 2.5 U/mL EPO, 50 n g l mL SCF, and 10 ng/mL IGF-l and 2.5 ng/mL bFGF (medium 2 ) . Single cells with the CD34+, CD38-, HLA-DR-phenotype were deposited into individual wells in a 96-well tissue culture plate containing 200 p L medium per well. After 10 days of culture, four different wells representing the four different growth patterns that we have observed were photographed at 400x using an inverted microscope. Growth properties of single sorted CD34', CD38-, HLA-DR-, CDSO' cells. CD34', CD38-, HLA-DR-cells that expressed CD50 were sorted into medium 1 or medium 2. The frequency of stromal progenitors (pattern 1) in media 1 (0.3%; n = 1) or media 2 (0%; n = 3 ) was significantly less than the frequency of stromal progenitors in the CD34'. CD38-, HLA-DR-, CDSO-population (3.3%; n = 1 l). In contrast, the frequency of hematopoietic progenitors within the population of CD34', CD38-, HLA-DR-, CD50' cells sorted into media with hematopoietic growth factors was 69% (n = 2), which was comparable with the frequency of hematopoietic progenitors when CD34', CD38-, HLA-DR' cells were sorted into media 2 (60% ? 14%). Therefore, the expression of CD50 was associated with nearly all the hematopoietic progenitors contained within the CD34', CD38-, HLA-DR-population, and lack of expression of CD50 was associated with nearly all the CD34', CD38-, HLA-DR-stromal progenitors.
Stromal cell growth under dtfferent culture conditions. Unfractionated fetal BM cells (1 X l @ to 2 X 10') were plated in each of six to eight wells in 96-well plates and assessed for their ability to form confluent layers of fibroblasts. In three separate experiments, confluent layers of fibroblasts were found in 7 I % to 1 0 0 % of the wells when the cells were plated into TF media, irrespective of the addition of b-FGF and/or IGF-I . In two of these experiments, serumfree medium (GIBCO ISA and GIBCO 16A), which supports the growth of hematopoietic progenitors when supplemented with a cocktail of recombinant growth factors,."' was tested for the potential to support stromal cell growth. Growth of confluent layers of fibroblasts was not found in any of the media tested. Addition of b-FGF and/or IGF-1 to the serum-free media also did not lead to stromal cell growth. Unknown factors present in the TF media, which contains 125% horse serum and 1 2 3 % fetal calf serum, seem, therefore, essential for stromal cell growth.
Stromal cell growth patterns from single sorted BM cells.
The data in the present report show that the CD34', CD38-. HLA-DR-cells grow initially as either hematopoietic or stromal cells. The data do not exclude the possibility of a stromal CD34'. CD38-, HLA-DR-progenitor giving rise to hematopoietic progeny after continued in vitro culture of the stromal Single cells that initially grew as adherent fibroblastic (stromal) cells, as shown in Fig 3A, produced stromal cultures with strikingly different growth patterns. Single CD34', CD38-, HLA-DR-cells were sorted, and the culture wells were scored after 3 to 4 weeks for the type of stromal growth pattern. Confluent layers of stromal cells ( Fig  5A) were seen at a frequency of 3.8% 5 6.3%. Stromal cells were organized into chords of stromal cells and fibrous tissue (Fig SB) at a frequency of 1.3% ? 0.9%. We also observed clusters of round cells attached to the stromal structures ( Fig  5C and E) at a frequency of 0.2% 5 0.6% or on the surface of these stromal monolayers (Fig SD and F ) at a frequency of 0.2% ? 0.3%. The other 94.8% of the wells contained cells that initially appeared as round and nonadherent and that either did not grow beyond 50 cells in media 1 and were presumed to be hematopoietic in origin (4.6% ? 4.9%). or showed no growth (89.9%). Given their mononuclear appearance and previous reports that similar round cells seen in stromal culture expressed hematopoietic marker^,'"'^ we investigated whether these nonadherent round cells might contain hematopoietic cells. First, we replated the stromal structures into two different media: medium I, containing bFGF and IGF-I in addition to the TF media and medium 2, containing bFGF, IGF-I, IL-3, IL-6, GM-CSF, EPO, and SCF added to the TF media. We reasoned that hematopoietic cells would require the presence of one or more hematopoietic growth factors that act on relatively undifferentiated cells for their growth in vitro. Each stromal structure was replated into four wells containing medium lacking hematopoietic growth factors (medium 1) or in medium containing the mixture of growth factors (medium 2). The results of replating the cultures that initially grew as stromal structures (as in Fig SB) were similar to the results of the primary culture of CD34'. CD38-, HLA-DR-cells: either they ( I ) did not grow; (2) formed a monolayer of adherent fibroblasts, similar to the cultures shown in Fig 5A; (3) formed a complex stromal structure, similar to that seen in Fig 5B; (4) formed clusters of round, nonadherent cells associated either with the fibroblast monolayer or the stromal structure similar to that seen in Fig 5C and D; Single cells with one of three phenotypes (CD34'. CD38-, HLA-DR.; CD34'. CD38-, HLA-DR-, CD50-; or CD34'. CD38-, HLA-DR') were sorted into individual wells of a 96-well tissue culture plate containing medium 1 or medium 2. In each set of experiments, the mean (?SD) and median number of wells containing cells with the growth of stromal cells (as in Fig 3A) or hematopoietic cells (as in Fig 3, B through D) were determined.
The median frequency of wells showing stromal cell growth was not statistically different between CD34'. CD38-, HLA-DR-and CD34' CD38.. HLA-DR-, CD50-populations and was independent of the presence or absence of hematopoietic growth factors.
CD34', CD38-, CD50-, HLA-DR.
CD34'. CD38-, HLA-DR+ similar to that seen in Fig 5F . There was no difference in the appearance of the replated cells, or in the percentages of wells with the different growth patterns in either medium 1 or in medium 2 ( Table 2) . In additional experiments, the initial growth pattern of other stromal cultures (of the types seen in Fig 5 ) , did not predict the growth pattern when the stromal cells were mechanically dissociated and replated (data not shown). Replating of stromal cells could be performed repetitively so that the progeny of a singly sorted cell could be expanded to the extent that sufficient nonadherent cells could be obtained after 1 to 2 months of culture for flow cytometric analysis. In cases in which only the nonadherent round cells (Fig 5E and F) were replated, they tended either not to grow or to form cultures consisting of mainly nonadherent cells and a few associated fibroblastic cells.
Morphology and immunophenotypic characteristics of the nonadherent cells harvested from the stromal cell structures. The morphology of the nonadherent cells harvested from the stromal cell structures showed a variety of cell types that appeared to represent differentiation along mesenchymal lineages (Fig 6) . When the nonadherent cells were selectively picked and cultured, most of the harvested cells were mononuclear, with a vacuolated cytoplasm and relatively low nucleus-to-cytoplasm ratio. Analysis of potential hematopoietic origin of these cells was assessed by immunophenotyping of cytospin preparations prepared from cells cultured in media with and without the presence of hematopoietic growth factors ( Table 3) . A variable number of the cells expressed CDIO, CD13, and CD49b. No expression of CD3, CD20, or CD34 was observed, and only a few cells stained weakly with CD43, CD45, or HLA-DR were observed. In contrast, unsorted fetal BM cells or the in vitro progeny of single CD34', CD38-, HLA-DR+ cells that had been sorted into a medium containing hematopoietic growth factors expressed heterogeneous but intense staining with CDIO, CD14, CD20, CD33, CD43, CD45, and HLA-DR. The morphologic appearance of Wright-Giemsa-stained cells from these sources was compared with that of the nonadherent cells obtained from the stromal cell layers derived from a single CD34+, CD38-, HLA-DR-cell and are shown in Fig 7A through Fig 3C) is shown in Fig 7B. These cells had the morphology of myelomonocytic blasts. In contrast, the CD34+, CD38-, HLA-DR-cells that were initially cultured in the absence of hematopoietic growth factors and then replated into medium containing hematopoietic growth factors had the appearance of histiocytes (Fig 7C) . Expression of CD34, HLA-DR, and CD13 of normal fetal BM cells, cultured CD34+, CD38-, HLA-DR' cells, and round nonadherent cells harvested from the stromal cell structures derived from single CD34', CD38-, HLA-DR-cells are shown in Fig 7D through directly conjugated MoAbs. A large heterogeneity in the expressed CD13 (Fig 8B) , and approximately 50% expressed forward and orthogonal light scatter profiles was observed, CD49b (Fig 8C) . However, they lacked expression of CD14, and a gate was placed to include cells of potential lymphoid CD19, CD34, CD43, CD50, and HLA-DR (Fig 8B through  or myeloid cell origin (Fig 8A) From a total of nine separate experiments, 65 stromal cultures (Fig  58) were each derived from singly sorted CD34'. CD38-., HLA-DRcells. The stromal cell structures were replated into four wells containing medium 1 and into four wells containing medium 2. The wells were scored for their growth pattern after 2 to 3 weeks of culture, using the different classifications shown in Fig 5. The mean frequency (+SD) of each growth pattern is shown.
. shown). Incubating the cell suspensions with directly conjugated, isotype-matched, irrelevant murine MoAbs (IgG I , IgG2a. IgG2b) did not result in any specific staining and was similar to the pattern seen in Fig 8E and F (data not  shown) .
DISCUSSION
Previous studies have claimed that long-term stromal cultures gave rise to hematopoietic cells, supporting the hypothesis of a common stem cell for both hematopoietic and stromal lineages. The present study was undertaken to establish the ontologic relationship between stromal and hematopoietic progenitors and to determine the phenotype of such a putative common stem cell.
We sorted over 30,000 CD34'. CD38-cells from 3 1 different fetal BM samples into single-tissue culture wells. In 864 instances of singly sorted cells, we observed the growth of fibroblast-like cells with elongated shapes spreading out on the surface of the culture dish, similar to the burst-forming unit-fibroblast (BFU-F) that has been previously described by For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From Mononuclear cells harvested from a stromal cell culture derived from a singly sorted CD34'. CD38-, HLA-DR-cell that had been cultured and replated for the initial 6 weeks in the absence of hematopoietic growth factors (medium 1) and then replated and cultured into media containing hematopoietic growth factors for an additional 2 weeks (medium 2). The cytospins were stained with Wright-Giemsa reagent (A through C) or with individual MoAbs as indicated in the left margin (D through I). The presence of bound primary antibody was shown as described in Materials and Methods, and then the slides were lightly counterstained with methylene blue. All slides were photographed at 400x original magnification.
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From Fig 3A) . The other two experiments gave identical staining patterns.
CD38-, HLA-DR-cells were heterogeneous with respect to light scatter properties, and we noted a higher frequency of clonogenic stromal cells in the fraction with a larger forward scatter (3% 2 4%) compared with smaller cells of the same phenotype (0.7% 2 0.4%). However, stromal cultures established from either small or large CD34+, CD38-, HLA-DRcells had identical growth properties. A single cell that produced a mixture of hematopoietic and stromal progeny was never observed. Within the CD34+ population, stromal progenitors were largely confined to the CD38-, HLA-DR-cell fraction, at mean and median frequencies of 4.1% and 3.6%, respectively ( Table 1) . Within the CD34', CD38-, HLA-DR' population, two stromal cells grew out of 960 single cells sorted, with a mean and median frequency (per experiment) of 0.2% and 0%, respectively ( Table 1) . Within the CD34+, CD38-, CDSO' , HLA-DR-population, stromal progenitors were also very rare, with growth of two stromal cells out of 720 cells sorted into media 1 (a frequency of 0.3%). The few stromal progenitors in the HLA-DR' or CDSO+ cell populations likely represent the inability of FACS to precisely resolve dim populations from negative and positive subsets. Direct sorting of 192 individual CD34+, CD38-, HLA-DR-dim, CD5O-dim cells resulted in the growth of a single stromal progenitor (a frequency of OS%), compared with 12 stromal cultures that resulted from sorting 576 CD34', CD38-, HLA-DR-cells in the same experiment (2.1%). Based on sorting fluorescent beads and the absence of mixed stromalhematopoietic cultures, the frequency of sorting cell doublets was less than 0.5% in these experiments. During continued culture, the fibroblastic CD34', CD38-, CD5O-FILA-DR-cells formed confluent monolayers attached to the bottom of the culture dish or gave rise to complex structures characterized by fibrous chords of cells suspended above the bottom of the culture plate. Both the stromal monolayers and structures had associated clusters of mononuclear cells at a frequency of 5% to 10%. The appearance of these structures and associated mononuclear cells was independent of the presence or absence of hematopoietic growth factors in the media. Although some of the mononuclear cells had the appearance of histiocytes, we did not observe cells that looked like eosinophils, basophils, lymphocytes, or megakaryocytes from these cultures. Two methods of immunophenotyping did not detect cells of hematopoietic origin in the nonadherent cells isolated from the For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From stromal structures. Although the correlation of morphology with surface phenotype for hematopoietic cells under longterm culture conditions may not be as strong as that for hematopoietic cells freshly isolated from peripheral blood, the hematopoietic progenitors (CD34+, CD38-, HLA-DR+) cultured in the presence of hematopoietic growth factors (media 2) had both morphology and immunophenotype typical of mature hematopoietic cells. In contrast, the mononuclear histiocytic cells isolated from clonal stromal cultures (initiated by singly sorted CD34+, CD38-, HLA-DR-cells) did not express a pattern of surface markers typical of hematopoietic cells (Table 3 and Fig 7) . The histiocytic cells from the stromal cultures lacked expression of CD1 I C and HLA-DR, antigens expressed at high levels on monocytes, and expression of CD68, an antigen associated with true histiocytes of hematopoietic origin (and some stromal cells"). The few cells that did show weak staining for CD43 and CD45 on cytospin preparations (Table 2) likely represent nonspecific staining, as this type of staining pattern was most often associated with degenerate cells.
The lack of evidence for a common stem cell in the present report is in contrast to the observations previously reported by two of us (S.H. and L.T.). 22 The conclusions of that report came into question based on a review of the primary data and led to a series of extensive experiments to reevaluate the common stem cell hypothesis. The results of this process led to the retraction of the previous publication by the investigatorsZ6 and to the new data presented herein. The difference between our present conclusions and those of other, earlier investigators may be explained by the use of transformed cell lines in the earlier experiments, the assignment of lineage based on a description of the morphology of cells in culture, or the use of a less specific i m m u n~a s s a y . '~~'~ W e interpret the expression of high levels of CD13, CD49b, and CD106/VCAM-l antigens on a large number of mononuclear cells from stromal cultures as being consistent with a mesenchymal origin for these The results of this study emphasizes the limitations in interpreting the lineage of cultured cells based on the appearance of the colony in culture and their morphology and stress the need for better methods to determine the lineage and phenotype of small numbers of cultured cells.
This study shows that clonogenic stromal progenitors can be isolated by single cell FACS from BM albeit at a low frequency. The overall plating efficiency of singly sorted CD34', CD38-, HLA-DR-stromal progenitor cells in either media 1 or media 2 ranged from 0% to 24%. The low frequency of clonogenic stromal cells that we observed in this study may be due to (1) the techniques we used to extract these cells from BM resulted in a low and variable number of stromal cells in the cell suspension; (2) functional heterogeneity within this population; (3) physical stresses on progenitors associated with single-cell sorting and suboptimal media conditions; or (4) a combination of these (as well as other) factors. The phenotypic and functional heterogeneity of the CD34+, CD38-, HLA-DR-population was confirmed by FACS analysis and single-cell sorting, which showed that these cells had heterogeneous light scatter properties, expressed surface antigens, and contained a mixture of stromal and hematopoietic progenitors. In contrast, the CD34', CD38-~, HLA-DR+ cells were much more homogeneous by FACS analysis, and an average of 60% of singly sorted cells were clonogenic hematopoietic progenitors. We have observed that the frequency of stromal progenitors in the CD34', CD38-, HLA-DR-population of fetal BM varies inversely with increasing fetal gestational age, whereas the frequency of hematopoietic progenitors in this population remains relatively constant, at about 5%." In contrast with previous studies on stromal progenitors isolated from adult BM,32 attempts to obtain stromal cell growth from singly sorted CD34+, CD38-, HLA-DR-in serum-free media supplemented with different combinations of IGF-1, bFGF, EGF or PDGF were unsuccessful. The serum in the media must, therefore, contain essential ingredients that supported the clonal outgrowth of stromal progenitors with the CD34', CD38-~, HLA-DR-KDSO-phenotype. Further investigations of the stromal progenitors in BM can be advanced by better methods of extracting stromal cells from BM and more defined culture conditions.
We conclude that hematopoietic progenitors are contained within the CD50' subset of fetal BM cells with the CD34', CD38-, HLA-DR-phenotype, whereas the stromal progenitors are contained within a separate population of CD34'. CD38-, HLA-DR-, CD50" cells. Based on our analysis of over 30,000 singly sorted fetal BM cells with a variety of CD34' phenotypes and 864 stromal cultures derived from single CD34' progenitors, there is no evidence to support the common stem cell hypothesis.
